Life Healthcare notes growth in revenue but fall in profit
Most of its divisions are growing with the number of patient days in its hospitals up by 10.2%
Life Healthcare will report a drop of up to 26% in headline earnings per share (HEPS) even as revenue grew and it saw increased patient stays in its hospitals and mental health clinics, and a rise in sales of its diagnostic drug used in the US for Alzheimer’s patients.
The group said HEPS would be 10%-26% lower as it faced rising costs including salaries, higher interest on debt, load-shedding and increased expenditure on IT. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.